IP Library Granted Patent US 12,700,100
Granted Patent B2
US 12,700,100 · App. 18/456,396 · Granted Aug 4, 2026

Methods for automatic target identification, tracking, and safety evaluation for radiotherapy

Inventors: Yevgen Voronenko (Sunnyvale, CA); Maksat Haytmyradov (Hayward, CA); Peter Demetri Olcott (Los Gatos, CA); Lingxiong Shao (Saratoga, CA); Manoj V. Narayanan (Mentor, OH)
Assignee: RefleXion Medical, Inc.
G06T7/11A61N5/103A61N5/1031A61N5/1039G06T7/0012G06T7/12G06T7/70G06T7/73A61N2005/1052G06T2207/10081G06T2207/10088G06T2207/10104G06T2207/10108G06T2207/10116G06T2207/20076G06T2207/30096
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,700,100
App. No.
18/456,396
Filed
Aug 25, 2023
Granted
Aug 4, 2026
Kind
B2
Art Unit
2661
USPC
382/103
Abstract

Disclosed herein are methods and systems for identifying the location of a target region using a tumor identification (ID) profile. A tumor ID profile includes identification parameters that characterize the target region. The tumor ID profile may be used to facilitate the identification of multiple target regions and to evaluate whether it is safe to deliver radiation to the target regions at their updated locations. Also disclosed herein are methods for analyzing a dose distribution to a target region by generating a bounded dose volume histogram (bDVH) based on gamma criteria comprising a distance-to-agreement (DTA) criterion and a dose difference (DD) criterion. In one variation, a gamma-derived bDVH is used in a method for selecting gamma criteria values for evaluating a radiotherapy treatment plan.

Claims (57)

1 . A method for locating a target region, the method comprising:

acquiring imaging data of a patient region that includes a tumor;

generating a map of pixel tumor likelihood values by calculating a tumor-likelihood value and background-likelihood value for each pixel of the imaging data; and

determining a location of the tumor by shifting a tumor contour within the imaging data to a centroid location of the map of pixel tumor likelihood values within a BTZ contour, wherein the BTZ contour encompasses the tumor contour.

2 . The method of claim 1 , wherein determining the location of the tumor further comprises:

iteratively updating the map of pixel tumor likelihood values to generate a final map of pixel tumor likelihood values such that an average pixel value within the shifted tumor contour is within a previously-defined threshold of an average pixel value within a pre-shifted tumor contour;

calculating a centroid location of the final map of pixel tumor likelihood values; and

determining the location of the tumor by shifting the tumor contour to the calculated centroid location.

3 . The method of claim 2 , wherein generating a map of pixel tumor likelihood values comprises calculating a tumor-likelihood value and background-likelihood value for each pixel in the acquired imaging data.

4 . The method of claim 3 , wherein calculating a tumor-likelihood value comprises calculating an average pixel value over the pixels within the tumor contour and a standard deviation value of the pixel values within the tumor contour.

5 . The method of claim 4 , wherein calculating a background-likelihood value comprises calculating an average pixel value over the pixels outside the tumor contour and within the BTZ contour and a standard deviation value of the pixel values outside the tumor contour and within the BTZ contour.

6 . The method of claim 5 , wherein iteratively updating the map of pixel tumor likelihood values comprises:

updating the map of pixel tumor probability values by assigning pixels within the shifted tumor contour a high tumor-probability value and assigning pixels outside the shifted tumor contour a low tumor-probability value;

updating tumor-likelihood values and background-likelihood values for each pixel in the acquired imaging data; and

adjusting the map of pixel tumor likelihood values using the updated map of pixel tumor probability values, updated tumor-likelihood values, and background-likelihood values.

7 . The method of claim 2 , further comprising generating a graphical representation that comprises the tumor contour that has been shifted to the centroid location of the final map of pixel tumor likelihood values, the acquired updated imaging data and displaying the graphical representation to a display device.

8 . The method of claim 1 , further comprising generating an initial map of pixel tumor probability values based on an initial image of the tumor, wherein the pixel tumor probability values are binary values and pixel likelihood values are any values greater than or equal to zero and less than or equal to one.

9 . The method of claim 1 , wherein the acquired imaging data of the tumor comprises one or more of PET imaging data, CT imaging data, MR imaging data, and X-ray imaging data.

10 . The method of claim 1 , further comprising generating an initial map of pixel tumor probability values based on an initial image of the tumor by assigning pixels within the tumor contour a high tumor-probability value and assigning pixels outside the tumor contour a low tumor-probability value.

11 . The method of claim 10 , wherein the high tumor-probability value is one and the low tumor-probability value is zero.

12 . The method of claim 1 , wherein acquiring imaging data comprises acquiring PET imaging data.

13 . The method of claim 1 , wherein acquiring imaging data comprises acquiring CT imaging data.

14 . The method of claim 1 , wherein acquiring imaging data comprises acquiring MR imaging data.

15 . The method of claim 1 , wherein acquiring imaging data comprises acquiring SPECT imaging data.

16 . The method of claim 1 , further comprising generating a graphical representation that comprises the tumor contour that has been shifted to the location of the tumor and displaying the graphical representation to a display device.

17 . The method of claim 16 , wherein the graphical representation further comprises the BTZ contour, and wherein the shifted tumor contour and BTZ contour are superimposed on the acquired imaging data.

18 . The method of claim 1 , further comprising generating a notification if a proximity of the shifted tumor contour to the BTZ contour is within a pre-determined margin.

19 . A method for evaluating a PET signal for radiotherapy, the method comprising:

acquiring PET imaging data of a patient region that includes a biology targeting zone (BTZ) region and a target region within the BTZ region;

determining a location of the target region within the BTZ region based on the PET imaging data;

calculating a target region standard uptake value (SUV) for pixels of the PET imaging data within the target region;

calculating a BTZ region SUV for pixels of the PET imaging data outside the target region and within the BTZ region;

calculating a normalized PET signal metric value of the target region using the target region SUV and the BTZ region SUV; and

evaluating the PET imaging data by comparing the normalized PET signal metric value with a planning PET signal metric value.

20 . The method of claim 19 , wherein comparing the normalized PET signal metric value with a planning PET signal metric value comprises calculating a predicted radiation dose for the target region based on the net PET signal metric value and comparing the predicted radiation dose with a prescribed radiation dose.

21 . The method of claim 19 , wherein determining the location of the target region comprises:

generating a map of pixel tumor likelihood values by calculating a tumor- likelihood value and background-likelihood value for each pixel of the PET imaging data;

shifting a contour of the target region to a centroid location of the map of pixel tumor likelihood values;

iteratively updating the map of pixel tumor likelihood values to generate a final map of pixel tumor likelihood values such that an average pixel value within the shifted target region contour is within a previously-defined threshold of an average pixel value within a pre-shifted tumor contour;

calculating a centroid location of the final map of pixel tumor likelihood values; and

determining the target region location by shifting the target region contour to the calculated centroid location.

22 . A method of tracking a target region, the method comprising:

acquiring PET imaging data of a target region;

identifying, using the acquired PET imaging data and a tumor identification (ID) profile, a location of the target region;

determining whether the location of the target region is within a target region contour; and

generating a notification if the location of the target region is outside a target region contour.

23 . The method of claim 22 , wherein the target region contour is a biology-tracking zone (BTZ) contour.

24 . The method of claim 22 , wherein the target region contour is a planning target volume (PTV) contour.

25 . The method of claim 22 , further comprising generating an interlock to stop radiation delivery if the location of the target region is outside the target region contour.

26 . The method of claim 22 , wherein determining whether the location of the target region is within a target region contour comprises determining whether any portion of the target region is outside the target region contour, and the method further comprises generating an interlock to stop radiation delivery if any portion of the target region is outside the target region contour.

27 . The method of claim 22 , wherein the notification is a graphical user interface that comprises the location of the target region and the target region contour, and the method further comprises outputting the graphical user interface to a display device.

28 . The method of claim 22 , wherein the notification is an audible alert, and the method further comprises outputting the audible alert to a speaker device.

29 . A method of tracking a target region, the method comprising:

acquiring PET imaging data of a target region;

identifying, using the acquired PET imaging data, a location of the target region, and wherein identifying the location of the target region comprises generating a map of pixel tumor likelihood values by calculating a tumor-likelihood value and background-likelihood value for each pixel of the PET imaging data and identifying the location of the target region by shifting a tumor contour within the PET imaging data to a centroid location of the map of pixel tumor likelihood values;

determining whether the location of the target region is within a target region contour; and

generating a notification if the location of the target region is outside a target region contour.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2024
From: VORONENKO, YEVGEN; HAYTMYRADOV, MAKSAT; OLCOTT, PETER DEMETRI; SHAO, LINGXIONG; NARAYANAN, MANOJ V.; ZDASIUK, GEORGE ANDREW
To: REFLEXION MEDICAL, INC.
Reel/Frame 067550/0103 →
Continuity (5)
Continuation PCTUS2022017375 · Feb 22, 2022
Provisional Application 63246212 · Sep 20, 2021
Provisional Application 63221859 · Jul 14, 2021
Provisional Application 63154295 · Feb 26, 2021
Related Publication 20240104767A1 · Mar 28, 2024
References Cited (400)
US 3794840A · Scott · 1974 [cited by applicant]
US 3906233A · Vogel · 1975 [cited by applicant]
US 4389569A · Hattori et al. · 1983 [cited by applicant]
US 4503331A · Kovacs, Jr. et al. · 1985 [cited by applicant]
US 4529882A · Lee · 1985 [cited by applicant]
US 4563582A · Mullani · 1986 [cited by applicant]
US 4575868A · Ueda et al. · 1986 [cited by applicant]
US 4642464A · Mullani · 1987 [cited by applicant]
US 4647779A · Wong · 1987 [cited by applicant]
US 4677299A · Wong · 1987 [cited by applicant]
US 4868844A · Nunan · 1989 [cited by applicant]
US 5015851A · Singh et al. · 1991 [cited by applicant]
US 5075554A · Yunker et al. · 1991 [cited by applicant]
US 5206512A · Iwao · 1993 [cited by applicant]
US 5207223A · Adler · 1993 [cited by applicant]
US 5317616A · Swerdloff et al. · 1994 [cited by applicant]
US 5329567A · Ikebe · 1994 [cited by applicant]
US 5351280A · Swerdloff et al. · 1994 [cited by applicant]
US 5390225A · Hawman · 1995 [cited by applicant]
US 5394452A · Swerdloff et al. · 1995 [cited by applicant]
US 5396534A · Thomas · 1995 [cited by applicant]
US 5418827A · Deasy et al. · 1995 [cited by applicant]
US 5442675A · Swerdloff et al. · 1995 [cited by applicant]
US 5548627A · Swerdloff et al. · 1996 [cited by applicant]
US 5647663A · Holmes · 1997 [cited by applicant]
US 5661773A · Swerdloff et al. · 1997 [cited by applicant]
US 5724400A · Swerdloff et al. · 1998 [cited by applicant]
US 5751781A · Brown et al. · 1998 [cited by applicant]
US 5813985A · Carroll · 1998 [cited by applicant]
US 5818902A · Yu · 1998 [cited by applicant]
US 5851182A · Sahadevan · 1998 [cited by applicant]
US 5937028A · Tybinkowski et al. · 1999 [cited by applicant]
US 6180943B1 · Lange · 2001 [cited by applicant]
US 6184530B1 · Hines et al. · 2001 [cited by applicant]
US 6188748B1 · Pastyr et al. · 2001 [cited by applicant]
US 6239438B1 · Schubert · 2001 [cited by applicant]
US 6260005B1 · Yang et al. · 2001 [cited by applicant]
US 6281505B1 · Hines et al. · 2001 [cited by applicant]
US 6385288B1 · Kanematsu · 2002 [cited by applicant]
US 6449331B1 · Nutt et al. · 2002 [cited by applicant]
US 6449340B1 · Tybinkowski et al. · 2002 [cited by applicant]
US 6455856B1 · Gagnon · 2002 [cited by applicant]
US 6473634B1 · Barni · 2002 [cited by applicant]
US 6504899B2 · Pugachev et al. · 2003 [cited by applicant]
US 6552693B1 · Leisten · 2003 [cited by applicant]
US 6560311B1 · Shepard et al. · 2003 [cited by applicant]
US 6618467B1 · Ruchala et al. · 2003 [cited by applicant]
US 6661866B1 · Limkeman et al. · 2003 [cited by applicant]
US 6696694B2 · Pastyr et al. · 2004 [cited by applicant]
US 6700949B2 · Susami et al. · 2004 [cited by applicant]
US 6714620B2 · Caflisch et al. · 2004 [cited by applicant]
US 6730924B1 · Pastyr et al. · 2004 [cited by applicant]
US 6735277B2 · McNutt et al. · 2004 [cited by applicant]
US 6794653B2 · Wainer et al. · 2004 [cited by applicant]
US 6810103B1 · Tybinkowski et al. · 2004 [cited by applicant]
US 6831961B1 · Tybinkowski et al. · 2004 [cited by applicant]
US 6865254B2 · Näfstadius · 2005 [cited by applicant]
US 6888919B2 · Graf · 2005 [cited by applicant]
US 6914959B2 · Bailey et al. · 2005 [cited by applicant]
US 6934363B2 · Seufert · 2005 [cited by applicant]
US 6965661B2 · Kojima et al. · 2005 [cited by applicant]
US 6976784B2 · Kojima et al. · 2005 [cited by applicant]
US 6990175B2 · Nakashima et al. · 2006 [cited by applicant]
US 7020233B1 · Tybinkowski et al. · 2006 [cited by applicant]
US 7026622B2 · Kojima et al. · 2006 [cited by applicant]
US 7110808B2 · Adair · 2006 [cited by applicant]
US 7154096B2 · Amano · 2006 [cited by applicant]
US 7167542B2 · Juschka et al. · 2007 [cited by applicant]
US 7199382B2 · Rigney et al. · 2007 [cited by applicant]
US 7227925B1 · Mansfield et al. · 2007 [cited by applicant]
US 7242750B2 · Tsujita · 2007 [cited by applicant]
US 7263165B2 · Ghelmansarai · 2007 [cited by applicant]
US 7265356B2 · Pelizzari et al. · 2007 [cited by applicant]
US 7280633B2 · Cheng et al. · 2007 [cited by applicant]
US 7291840B2 · Fritzler et al. · 2007 [cited by applicant]
US 7297958B2 · Kojima et al. · 2007 [cited by applicant]
US 7298821B2 · Ein-Gal · 2007 [cited by applicant]
US 7310410B2 · Sohal et al. · 2007 [cited by applicant]
US 7386099B1 · Kasper et al. · 2008 [cited by applicant]
US 7397901B1 · Johnsen · 2008 [cited by applicant]
US 7397902B2 · Seeber et al. · 2008 [cited by applicant]
US 7453983B2 · Schildkraut et al. · 2008 [cited by applicant]
US 7453984B2 · Chen et al. · 2008 [cited by applicant]
US 7469035B2 · Keall et al. · 2008 [cited by applicant]
US 7555103B2 · Johnsen · 2009 [cited by applicant]
US 7558378B2 · Juschka et al. · 2009 [cited by applicant]
US 7560698B2 · Rietzel · 2009 [cited by applicant]
US 7564951B2 · Hasegawa et al. · 2009 [cited by applicant]
US 7596209B2 · Perkins · 2009 [cited by applicant]
US 7627082B2 · Kojima et al. · 2009 [cited by applicant]
US 7639853B2 · Olivera et al. · 2009 [cited by applicant]
US 7656999B2 · Hui et al. · 2010 [cited by applicant]
US 7715606B2 · Jeung et al. · 2010 [cited by applicant]
US 7742575B2 · Bourne · 2010 [cited by applicant]
US 7755055B2 · Schilling · 2010 [cited by applicant]
US 7755057B2 · Kim · 2010 [cited by applicant]
US 7778691B2 · Zhang et al. · 2010 [cited by applicant]
US 7792252B2 · Bohn · 2010 [cited by applicant]
US 7795590B2 · Takahashi et al. · 2010 [cited by applicant]
US 7839972B2 · Ruchala et al. · 2010 [cited by applicant]
US 7885371B2 · Thibault et al. · 2011 [cited by applicant]
US 7949095B2 · Ning et al. · 2011 [cited by applicant]
US 7957507B2 · Cadman · 2011 [cited by applicant]
US 7965819B2 · Nagata · 2011 [cited by applicant]
US 7983380B2 · Guertin et al. · 2011 [cited by applicant]
US 8059782B2 · Brown · 2011 [cited by applicant]
US 8063376B2 · Maniawski et al. · 2011 [cited by applicant]
US 8093568B2 · Mackie et al. · 2012 [cited by applicant]
US 8116427B2 · Kojima et al. · 2012 [cited by applicant]
US 8139713B2 · Janbakhsh · 2012 [cited by applicant]
US 8139714B1 · Sahadevan · 2012 [cited by applicant]
US 8144962B2 · Busch et al. · 2012 [cited by applicant]
US 8148695B2 · Takahashi et al. · 2012 [cited by applicant]
US 8160205B2 · Saracen et al. · 2012 [cited by applicant]
US 8232535B2 · Olivera et al. · 2012 [cited by applicant]
US 8280002B2 · Bani-Hashemi et al. · 2012 [cited by applicant]
US 8295906B2 · Saunders et al. · 2012 [cited by applicant]
US 8304738B2 · Gagnon et al. · 2012 [cited by applicant]
US 8335296B2 · Dehler et al. · 2012 [cited by applicant]
US 8357903B2 · Wang et al. · 2013 [cited by applicant]
US 8384049B1 · Broad · 2013 [cited by applicant]
US 8406844B2 · Ruchala et al. · 2013 [cited by applicant]
US 8442287B2 · Fordyce, II et al. · 2013 [cited by applicant]
US 8447387B2 · Xu et al. · 2013 [cited by applicant]
US 8461539B2 · Yamaya et al. · 2013 [cited by applicant]
US 8483803B2 · Partain et al. · 2013 [cited by applicant]
US 8536547B2 · Maurer, Jr. et al. · 2013 [cited by applicant]
US 8537373B2 · Humphrey · 2013 [cited by applicant]
US 8581196B2 · Yamaya et al. · 2013 [cited by applicant]
US 8588367B2 · Busch et al. · 2013 [cited by applicant]
US 8606349B2 · Rousso et al. · 2013 [cited by applicant]
US 8617422B2 · Koschan et al. · 2013 [cited by applicant]
US 8641592B2 · Yu · 2014 [cited by applicant]
US 8664610B2 · Chuang · 2014 [cited by applicant]
US 8664618B2 · Yao · 2014 [cited by applicant]
US 8712012B2 · O'Connor · 2014 [cited by applicant]
US 8716669B2 · Miyaoka et al. · 2014 [cited by applicant]
US 8745789B2 · Saracen et al. · 2014 [cited by applicant]
US 8748825B2 · Mazin · 2014 [cited by applicant]
US 8767917B2 · Ruchala et al. · 2014 [cited by applicant]
US 9155909B2 · Ishikawa · 2015 [cited by applicant]
US 9283403B2 · Mazin et al. · 2016 [cited by applicant]
US 9649509B2 · Mazin et al. · 2017 [cited by applicant]
US 9694208B2 · Mazin et al. · 2017 [cited by applicant]
US 9731148B2 · Olivera et al. · 2017 [cited by applicant]
US 9764161B2 · Mazin et al. · 2017 [cited by applicant]
US 9895554B2 · Nguyen · 2018 [cited by examiner]
US 10143857B2 · Mazin et al. · 2018 [cited by applicant]
US 10159852B2 · Mazin et al. · 2018 [cited by applicant]
US 10166405B2 · Nguyen · 2019 [cited by examiner]
US 10456600B2 · Owens · 2019 [cited by examiner]
US 10617890B2 · Mazin et al. · 2020 [cited by applicant]
US 10688320B2 · Voronenko · 2020 [cited by examiner]
US 10695583B2 · Mazin et al. · 2020 [cited by applicant]
US 10745253B2 · Saracen et al. · 2020 [cited by applicant]
US 10918884B2 · O'Connor et al. · 2021 [cited by applicant]
US 10946215B2 · Sjolund · 2021 [cited by examiner]
US 10960230B2 · Nguyen · 2021 [cited by examiner]
US 11033757B2 · Voronenko · 2021 [cited by examiner]
US 11141607B2 · Mazin et al. · 2021 [cited by applicant]
US 11358008B2 · Voronenko et al. · 2022 [cited by applicant]
US 11406846B2 · Voronenko et al. · 2022 [cited by applicant]
US 11633626B2 · Voronenko · 2023 [cited by examiner]
US 11801398B2 · Voronenko et al. · 2023 [cited by applicant]
US 12002216B2 · Albrecht · 2024 [cited by examiner]
US 12115386B2 · Voronenko · 2024 [cited by examiner]
US 12214218B2 · Kolesnick · 2025 [cited by examiner]
US 12233286B2 · Voronenko et al. · 2025 [cited by applicant]
US 12303718B2 · Owens · 2025 [cited by examiner]
US 20020051513A1 · Pugachev et al. · 2002 [cited by applicant]
US 20020163994A1 · Jones · 2002 [cited by applicant]
US 20020191734A1 · Kojima et al. · 2002 [cited by applicant]
US 20020193685A1 · Mate et al. · 2002 [cited by applicant]
US 20030036700A1 · Weinberg · 2003 [cited by applicant]
US 20030128801A1 · Eisenberg et al. · 2003 [cited by applicant]
US 20030219098A1 · McNutt et al. · 2003 [cited by applicant]
US 20030235531A1 · Adair · 2003 [cited by applicant]
US 20040024300A1 · Graf · 2004 [cited by applicant]
US 20040030246A1 · Townsend et al. · 2004 [cited by applicant]
US 20040057557A1 · Nafstadius · 2004 [cited by applicant]
US 20040158416A1 · Slates · 2004 [cited by applicant]
US 20050213705A1 · Hoffman · 2005 [cited by applicant]
US 20050228255A1 · Saracen et al. · 2005 [cited by applicant]
US 20060072699A1 · Mackie et al. · 2006 [cited by applicant]
US 20060113482A1 · Pelizzari et al. · 2006 [cited by applicant]
US 20060173294A1 · Ein-Gal · 2006 [cited by applicant]
US 20060182326A1 · Schildkraut et al. · 2006 [cited by applicant]
US 20060193435A1 · Hara et al. · 2006 [cited by applicant]
US 20060237652A1 · Kimchy et al. · 2006 [cited by applicant]
US 20070014391A1 · Mostafavi et al. · 2007 [cited by applicant]
US 20070025513A1 · Ghelmansarai · 2007 [cited by applicant]
US 20070041500A1 · Olivera et al. · 2007 [cited by applicant]
US 20070043289A1 · Adair · 2007 [cited by applicant]
US 20070053491A1 · Schildkraut et al. · 2007 [cited by applicant]
US 20070055144A1 · Neustadter et al. · 2007 [cited by applicant]
US 20070075273A1 · Birgy et al. · 2007 [cited by applicant]
US 20070085012A1 · Thompson · 2007 [cited by applicant]
US 20070211857A1 · Urano et al. · 2007 [cited by applicant]
US 20070221869A1 · Song · 2007 [cited by applicant]
US 20070242801A1 · Mackie et al. · 2007 [cited by applicant]
US 20070265230A1 · Rousso et al. · 2007 [cited by applicant]
US 20070265528A1 · Xu et al. · 2007 [cited by applicant]
US 20080002811A1 · Allison · 2008 [cited by applicant]
US 20080031404A1 · Khamene et al. · 2008 [cited by applicant]
US 20080128631A1 · Suhami · 2008 [cited by applicant]
US 20080130825A1 · Fu et al. · 2008 [cited by applicant]
US 20080152085A1 · Saracen et al. · 2008 [cited by applicant]
US 20080156993A1 · Weinberg et al. · 2008 [cited by applicant]
US 20080177179A1 · Stubbs et al. · 2008 [cited by applicant]
US 20080205588A1 · Kim · 2008 [cited by applicant]
US 20080230705A1 · Rousso et al. · 2008 [cited by applicant]
US 20080253516A1 · Hui et al. · 2008 [cited by applicant]
US 20080273659A1 · Guertin et al. · 2008 [cited by applicant]
US 20080298536A1 · Ein-Gal · 2008 [cited by applicant]
US 20090003655A1 · Wollenweber · 2009 [cited by applicant]
US 20090086909A1 · Hui et al. · 2009 [cited by applicant]
US 20090116616A1 · Lu et al. · 2009 [cited by applicant]
US 20090169082A1 · Mizuta et al. · 2009 [cited by applicant]
US 20090256078A1 · Mazin · 2009 [cited by applicant]
US 20090309046A1 · Balakin · 2009 [cited by applicant]
US 20100040197A1 · Maniawski et al. · 2010 [cited by applicant]
US 20100054412A1 · Brinks et al. · 2010 [cited by applicant]
US 20100067660A1 · Maurer, Jr. et al. · 2010 [cited by applicant]
US 20100069742A1 · Partain et al. · 2010 [cited by applicant]
US 20100074400A1 · Sendai · 2010 [cited by applicant]
US 20100074408A1 · Bert et al. · 2010 [cited by applicant]
US 20100074498A1 · Breeding et al. · 2010 [cited by applicant]
US 20100166274A1 · Busch et al. · 2010 [cited by applicant]
US 20100176309A1 · Mackie et al. · 2010 [cited by applicant]
US 20100198063A1 · Huber et al. · 2010 [cited by applicant]
US 20100220832A1 · Ning et al. · 2010 [cited by applicant]
US 20100237259A1 · Wang · 2010 [cited by applicant]
US 20100258138A1 · Sorensen et al. · 2010 [cited by applicant]
US 20110006212A1 · Shchory et al. · 2011 [cited by applicant]
US 20110044429A1 · Takahashi et al. · 2011 [cited by applicant]
US 20110073763A1 · Subbarao · 2011 [cited by applicant]
US 20110092814A1 · Yamaya et al. · 2011 [cited by applicant]
US 20110215248A1 · Lewellen et al. · 2011 [cited by applicant]
US 20110249088A1 · Hannibal et al. · 2011 [cited by applicant]
US 20110272600A1 · Bert et al. · 2011 [cited by applicant]
US 20110297833A1 · Takayama · 2011 [cited by applicant]
US 20110309252A1 · Moriyasu et al. · 2011 [cited by applicant]
US 20110309255A1 · Bert et al. · 2011 [cited by applicant]
US 20110313231A1 · Guertin et al. · 2011 [cited by applicant]
US 20110313232A1 · Balakin · 2011 [cited by applicant]
US 20120138804A1 · Miyaoka et al. · 2012 [cited by applicant]
US 20120161014A1 · Yamaya et al. · 2012 [cited by applicant]
US 20120174317A1 · Saracen et al. · 2012 [cited by applicant]
US 20120230464A1 · Ling et al. · 2012 [cited by applicant]
US 20120320055A1 · Pekar et al. · 2012 [cited by applicant]
US 20130025055A1 · Saracen et al. · 2013 [cited by applicant]
US 20130060134A1 · Eshima et al. · 2013 [cited by applicant]
US 20130102830A1 · Otto · 2013 [cited by applicant]
US 20130266116A1 · Abenaim et al. · 2013 [cited by applicant]
US 20140105355A1 · Toimela et al. · 2014 [cited by applicant]
US 20140107390A1 · Brown et al. · 2014 [cited by applicant]
US 20140107460A1 · Nguyen · 2014 [cited by examiner]
US 20140163368A1 · Rousso et al. · 2014 [cited by applicant]
US 20140193336A1 · Rousso et al. · 2014 [cited by applicant]
US 20140217294A1 · Rothfuss et al. · 2014 [cited by applicant]
US 20140228613A1 · Mazin · 2014 [cited by examiner]
US 20140239204A1 · Orton et al. · 2014 [cited by applicant]
US 20140257096A1 · Prevrhal et al. · 2014 [cited by applicant]
US 20140275962A1 · Foo · 2014 [cited by examiner]
US 20150055849A1 · Galavis et al. · 2015 [cited by applicant]
US 20150087960A1 · Treffert · 2015 [cited by applicant]
US 20150094519A1 · Kuusela · 2015 [cited by examiner]
US 20150251017A1 · De Crevoisier et al. · 2015 [cited by applicant]
US 20150355347A1 · Pratx · 2015 [cited by applicant]
US 20150367143A1 · Muraki et al. · 2015 [cited by applicant]
US 20160296766A1 · El Fakhri et al. · 2016 [cited by applicant]
US 20160331997A1 · Vilsmeier · 2016 [cited by applicant]
US 20160361566A1 · Larkin et al. · 2016 [cited by applicant]
US 20170014642A1 · An et al. · 2017 [cited by applicant]
US 20170368372A1 · Mazin et al. · 2017 [cited by applicant]
US 20180001109A1 · Mazin et al. · 2018 [cited by applicant]
US 20180369611A1 · Owens · 2018 [cited by examiner]
US 20190001152A1 · O'Connor et al. · 2019 [cited by applicant]
US 20190083815A1 · Mazin et al. · 2019 [cited by applicant]
US 20190091487A1 · Pal et al. · 2019 [cited by applicant]
US 20190255362A1 · Voronenko et al. · 2019 [cited by applicant]
US 20190262630A1 · Voronenko · 2019 [cited by examiner]
US 20200016432A1 · Maolinbay · 2020 [cited by examiner]
US 20220096867A1 · Mazin et al. · 2022 [cited by applicant]
US 20230067048A1 · Voronenko et al. · 2023 [cited by applicant]
US 20230230253A1 · Albrecht · 2023 [cited by examiner]
US 20230256266A1 · Voronenko · 2023 [cited by examiner]
US 20230285777A1 · Bassalow · 2023 [cited by examiner]
US 20240082605A1 · Voronenko et al. · 2024 [cited by applicant]
US 20240189624A1 · Olcott · 2024 [cited by examiner]
US 20250121211A1 · Mazin · 2025 [cited by examiner]
US 20250262460A1 · Voronenko et al. · 2025 [cited by applicant]
CA 1121072A · 1982 [cited by applicant]
CN 1681436A · 2005 [cited by applicant]
CN 1960780A · 2007 [cited by applicant]
CN 101013095A · 2007 [cited by applicant]
CN 101247852A · 2008 [cited by applicant]
CN 101305297A · 2008 [cited by applicant]
CN 101970043A · 2011 [cited by applicant]
CN 102068763A · 2011 [cited by applicant]
CN 102160913A · 2011 [cited by applicant]
CN 102553089A · 2012 [cited by applicant]
CN 102641561A · 2012 [cited by applicant]
CN 103006253A · 2013 [cited by applicant]
CN 103126713A · 2013 [cited by applicant]
CN 103517737A · 2014 [cited by applicant]
CN 103845068A · 2014 [cited by applicant]
CN 104866928A · 2015 [cited by applicant]
CN 104994909A · 2015 [cited by applicant]
DE 102008053321A1 · 2010 [cited by applicant]
EP 1402761B1 · 2008 [cited by applicant]
EP 2188815B1 · 2010 [cited by applicant]
EP 1660175B1 · 2012 [cited by applicant]
EP 2687259A1 · 2014 [cited by applicant]
EP 2777768A1 · 2014 [cited by applicant]
EP 3175886B1 · 2018 [cited by applicant]
JP 0933658A · 1997 [cited by applicant]
JP 9189769A2 · 1997 [cited by applicant]
JP 2000105279A · 2000 [cited by applicant]
JP 2001340474A · 2001 [cited by applicant]
JP 2002522128A · 2002 [cited by applicant]
JP 2003534823A · 2003 [cited by applicant]
JP 2004073404A · 2004 [cited by applicant]
JP 2004513735A · 2004 [cited by applicant]
JP 2006007464A · 2006 [cited by applicant]
JP 2006145281A · 2006 [cited by applicant]
JP 2007502166A · 2007 [cited by applicant]
JP 2007507246A · 2007 [cited by applicant]
JP 2007083036A · 2007 [cited by applicant]
JP 2008173299A · 2008 [cited by applicant]
JP 2009005440A · 2009 [cited by applicant]
JP 2009502249A · 2009 [cited by applicant]
JP 2009544101A · 2009 [cited by applicant]
JP 2010517655A · 2010 [cited by applicant]
JP 2011514213A · 2011 [cited by applicant]
JP 2011528977A · 2011 [cited by applicant]
JP 2012035072A · 2012 [cited by applicant]
JP 2014023741A · 2014 [cited by applicant]
JP 2016168077A · 2016 [cited by applicant]
JP 6210972B2 · 2017 [cited by applicant]
JP 6571816B2 · 2019 [cited by applicant]
JP 6796886B2 · 2020 [cited by applicant]
JP 7274773B2 · 2023 [cited by applicant]
WO WO8910090A1 · 1989 [cited by applicant]
WO WO9428971A2 · 1994 [cited by applicant]
WO WO9428971A3 · 1994 [cited by applicant]
WO WO00015299A1 · 2000 [cited by applicant]
WO WO2004017832A2 · 2004 [cited by applicant]
WO WO2004017832A3 · 2004 [cited by applicant]
WO WO2005018734A2 · 2005 [cited by applicant]
WO WO2005018734A3 · 2005 [cited by applicant]
WO WO2005018735A2 · 2005 [cited by applicant]
WO WO2005018735A3 · 2005 [cited by applicant]
WO WO2005110495A1 · 2005 [cited by applicant]
WO WO2007045076A1 · 2007 [cited by applicant]
WO WO2007124760A1 · 2007 [cited by applicant]
WO WO2008019118A2 · 2008 [cited by applicant]
WO WO2008024463A2 · 2008 [cited by applicant]
WO WO2008024463A3 · 2008 [cited by applicant]
WO WO2009111580A2 · 2009 [cited by applicant]
WO WO2009111580A3 · 2009 [cited by applicant]
WO WO2009114117A2 · 2009 [cited by applicant]
WO WO2010015358A1 · 2010 [cited by applicant]
WO WO2010018477A2 · 2010 [cited by applicant]
WO WO2010018477A3 · 2010 [cited by applicant]
WO WO2010110255A1 · 2010 [cited by applicant]
WO WO2012135771A1 · 2012 [cited by applicant]
WO WO2013093852A1 · 2013 [cited by applicant]
WO WO2015168431A1 · 2015 [cited by applicant]
WO WO2016061877A1 · 2016 [cited by applicant]
WO WO2016064750A1 · 2016 [cited by applicant]
WO WO2017048852A1 · 2017 [cited by applicant]
WO WO2017156316A1 · 2017 [cited by applicant]
WO WO2018093933A1 · 2018 [cited by applicant]
WO WO2018222751A1 · 2018 [cited by applicant]
WO WO2019060764A1 · 2019 [cited by applicant]
WO WO2020144134A1 · 2020 [cited by applicant]
WO WO2021011207A1 · 2021 [cited by applicant]
Bangert, M. et al. (2016). “Accelerated iterative beam angle selection in IMRT,” Medical Physics 43.3:1073-1082. [cited by applicant]
Bao, Q. et al. (2010). “Estimation of the minimum detectable activity of preclinical PET imaging systems with an analytical method,” Med. Phys. 37:6070-6083. [cited by applicant]
Chang, J.Y. et al. (2008). “Image-Guided Radiation Therapy for Non-Small Cell Lung Cancer,” [cited by applicant]
Chen, X. et al. (2012). “Smoothing proximal gradient method for general structured sparse regression,” The Annals of Applied Statistics 6:719-752. [cited by applicant]
Dieterich, S. et al. (2003). “Skin respiratory motion tracking for stereotactic radiosurgery using the CyberKnife,” [cited by applicant]
Erdi, Y.E. (Feb. 2007). “The Use of PET for Radiotherapy,” [cited by applicant]
Extended European Search Report mailed on Oct. 7, 2015, for European Application No. 12 763 280.0, filed on Mar. 30, 2012, 11 pages. [cited by applicant]
Extended European Search Report mailed on Nov. 21, 2018, for European Application No. 18 168 947.2, filed on Mar. 30, 2012, 8 pages. [cited by applicant]
Extended European Search Report mailed on Oct. 15, 2019, for European Application No. 17 764 132.1, filed on Mar. 9, 2017, 4 pages. [cited by applicant]
Extended European Search Report mailed on Oct. 15, 2021, for European Application No. 19 754 923.1, filed on Feb. 13, 2019, 11 pages. [cited by applicant]
Fan, Q. (Nov. 2012). “Emission Guided Radiation Therapy for Lung and Prostrate Cancers: A Feasibility Study on a Digital Patient,” [cited by applicant]
Fan, Q. et al. (Aug. 2013). “Toward a Planning Scheme for Emission Guided Radiation Therapy (EGRT): FDG Based Tumor Tracking in a Metastatic Breast Cancer Patient,” [cited by applicant]
Final Office Action mailed on Aug. 2, 2018, for U.S. Appl. No. 15/684,710, filed Aug. 23, 2017, 8 pages. [cited by applicant]
Final Office Action mailed on Aug. 21, 2023, for U.S. Appl. No. 17/485,059, filed Sep. 24, 2021, 10 pages. [cited by applicant]
Fredriksson (2013). “Robust optimization of radiation therapy accounting for geometric uncertainty,” KTH Engin. Sciences, pp. 8-14. [cited by applicant]
Gibbons, J.P. (2004). “Dose calculation and verification for tomotherapy,” 2004 ACMP Meeting, Scottsdale, AZ., 71 total pages. [cited by applicant]
Handsfield, L.L. et al. (2014). “Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation,” [cited by applicant]
Internal Atomic Energy Agency (Oct. 2008). “The Role of PET/CT in Radiation Treatment Planning for Cancer Patient Treatment,” located at https://www-pub.iaea.org/MTCD/Publications/PDF/te_1603_web.pdf, 40 total pages. [cited by applicant]
International Search Report mailed on Jul. 20, 2012, for PCT Patent Application No. PCT/US2012/31704, filed on Mar. 30, 2012, 2 pages. [cited by applicant]
International Search Report mailed on Jun. 27, 2017, for PCT Patent Application No. PCT/US2017/021647, filed on Mar. 9, 2017, 3 pages. [cited by applicant]
Japanese Office Action mailed Dec. 25, 2015, For Japanese Patent Application No. 2014-502881 filed Mar. 20, 2012, 14 pages (with English Translation). [cited by applicant]
Kapatoes, J.M. et al. (2001). “A feasible method for clinical delivery verification and dose reconstruction in tomotherapy,” [cited by applicant]